glp 1 and seizures Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy associated comorbidities GLP-1 receptor agonists in people

Evidence-based insights for patients and providers.

In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide

Prescription required and reviewed by clinician

GLP-1 Probiotic+ Benefits: Digestive Support: Clostridium butyricum may help maintain balance in the digestive system

Ifaccess to the CMWL Program at a local participating center is not an option,itmay bepossibleto follow it online with a nurse practitioner trained in the proprietary, clinically-proven CMWL weight loss protocols